SEED Innovations Reports 14% Portfolio Growth Amid 74% NAV Discount and Chairman Exit
SEED Innovations reveals 14% portfolio growth to £8.3m but trades at 74% NAV discount amid chairman exit. Cash buffer and strategic options in focus. [Character count: 155]
This article covers information on Seed Innovations Limited.
LON:LYZ1SEED Innovations has just dropped its final results for the year ending March 2025, and there’s plenty to unpack. On the surface, we’ve got a 14% portfolio growth to £8.3 million and a robust £3.4 million cash war chest. But dig deeper, and the real story emerges: shares are trading at a jaw-dropping 74% discount to NAV, while Chairman Ian Burns prepares to exit stage left. Let’s slice through the RNS and see what this means for investors.
Portfolio Performance: Gains, Pains, and Strategic Plays
That 14% portfolio uplift didn’t happen by accident. SEED’s hybrid strategy-mixing long-term venture bets with tactical short-term trades-delivered despite what CEO Ed McDermott calls an “exceptionally challenging macroeconomic backdrop.” Here’s where the momentum came from:
Star Performers
- Avextra AG (Biotech/Cannabis): Up 13% to £3.1m. Why? Vertical integration from Portuguese cultivation to German production, plus new proprietary strain development.
- Clean Food Group (Biotech): Soared 45% to £1.7m. Their food-waste-to-oil tech scored a cosmetics deal with THG Labs and even landed a BBC feature.
- Inveniam (Fintech): Jumped 45% to £498k. Post-acquisition momentum and a strategic investment from UAE’s G42 boosted its AI-driven private markets platform.
Mixed Signals
- Juvenescence (Biotech): Slight dip to £2.5m due to FX, but masked huge progress-$76m Series B-1 raise with Abu Dhabi’s M42 and clinical breakthroughs in longevity therapeutics.
- Little Green Pharma (Cannabis): Down 16% to £443k on ASX price moves, but positioned to capitalise on Europe’s regulatory easing, especially in Germany and France.
Meanwhile, the short-term trading book generated tidy wins, like a 35% return on Pantheon Resources in just three months. Not life-changing money, but it proves SEED can pivot when liquidity dries up elsewhere.
Financial Health Check: The 74% Discount Elephant in the Room
Let’s address the glaring disconnect: a £11.8m NAV versus a market cap implied by a 1.6p share price. That 74% discount isn’t just steep-it’s cavernous. Yet the numbers tell a nuanced story:
- Cash Buffer: £3.4m in cash/receivables (29% of NAV) offers dry powder for deals or further buybacks.
- NAV Drag: The £11.8m NAV is down from £13.6m, but that’s largely due to the £2m special dividend and £0.2m buyback-not operational weakness.
- Cost Discipline: Operating expenses held flat at £744k despite inflation-a minor victory in this environment.
Burns didn’t mince words: this discount “significantly misrepresents the business.” Translation: either the market’s missing the plot, or SEED needs to force a rerating.
Strategic Crossroads: Buybacks, Dividends & The “What Next?”
Management’s sending clear signals with capital allocation:
- £2m Special Dividend: Rewarding patience while tacitly admitting deployment opportunities are scarce.
- Share Buybacks: Another £0.2m repurchased at fire-sale prices-logical when shares trade at 26p for every £1 of NAV.
The RNS hints at frustration: “If new investments aren’t made, we’ll look at other strategic options.” That’s boardroom code for “everything’s on the table”-potentially including a strategic review or even a winding-up vote if the discount persists.
Leadership Shuffle: Burns Out, Cairns In (For Now)
Ian Burns’ departure as Chair after this report lands feels symbolic. His farewell note stressed “realising SEED’s full potential,” implying unfinished business. Luke Cairns steps in as Interim Chair-a safe pair of hands, but his tenure feels like a holding pattern until either:
- Deployment accelerates, or
- The board pulls the lever on “strategic options.”
Worth noting: Burns remains a shareholder via Smoke Rise Holdings. He’s not cutting ties-just passing the baton.
Bottom Line: Discount as Catalyst?
SEED’s portfolio is ticking upward, but the discount is the story. For investors, this presents a binary bet:
- Bull Case: Cash + catalyst (new deals, liquidity events at Juvenescence/CFG) closes the gap. A 50% discount would still imply a 100%+ share price rally.
- Bear Case: The discount persists, forcing the board into radical action-asset sales, tender offers, or even a managed wind-down.
McDermott’s closing remarks ring true: “Prudent and opportunistic” sums up SEED’s stance. But patience wears thin at a 74% discount. One thing’s certain: the next 12 months will define whether this is a hidden gem or a permanent value trap.
Related
Keep reading
Investing
Brave Bison Raises System1 Offer to £47.5 Million as Delisting Stakes Grow
Brave Bison's fourth System1 offer values the target at £47.5 million, but the deal remains conditional on securing majority support.
JoshuaSeptember 14, 2026
Investing
Keras Resources pivots to Namibian copper with US phosphate sale and £1.7 million raise
Keras Resources is reshaping itself around Namibian copper, backed by a US phosphate disposal, royalties and a £1.7 million raise.
JoshuaSeptember 14, 2026
Investing
Empyrean Energy adds Austrian gas exposure as equity fundraising looms
Empyrean Energy has agreed an Austrian gas farm-in, but shareholders face exploration risk, a trading halt and likely equity dilution.
JoshuaSeptember 14, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.